Verrica Pharmaceuticals (VRCA) Receivables - Net (2023 - 2025)
Historic Receivables - Net for Verrica Pharmaceuticals (VRCA) over the last 3 years, with Q3 2025 value amounting to $7.0 million.
- Verrica Pharmaceuticals' Receivables - Net changed N/A to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year change of. This contributed to the annual value of $48000.0 for FY2024, which is 9887.01% down from last year.
- Latest data reveals that Verrica Pharmaceuticals reported Receivables - Net of $7.0 million as of Q3 2025.
- Verrica Pharmaceuticals' Receivables - Net's 5-year high stood at $10.0 million during Q2 2024, with a 5-year trough of $48000.0 in Q4 2024.
- Over the past 3 years, Verrica Pharmaceuticals' median Receivables - Net value was $6.3 million (recorded in 2024), while the average stood at $5.9 million.
- Its Receivables - Net has fluctuated over the past 5 years, first plummeted by 9887.01% in 2024, then tumbled by 823.86% in 2025.
- Verrica Pharmaceuticals' Receivables - Net (Quarter) stood at $4.2 million in 2023, then plummeted by 98.87% to $48000.0 in 2024, then soared by 14581.25% to $7.0 million in 2025.
- Its Receivables - Net stands at $7.0 million for Q3 2025, versus $9.2 million for Q2 2025 and $5.6 million for Q1 2025.